Research
Clinical Trials
A main objective of the PCM program is to to enhance the local machinery for early clinical trials and to optimize the collaboration with Cancer Core Europe.
task forces
Early clinical trials
PCM Task force chair: Claes Karlsson The objectives are to interact with the corresponding TF of CCE (currently a major focus on the BoB trial)
clinical trials
CCE Basket of Basket
The Basket of Baskets Clinical Trial is a Modular, Open-label, Phase II, Multicentre Study To Evaluate Targeted Agents in Molecularly Selected Populations With Advanced Solid Tumours.
Our network
The PCM program fosters a global network in translational cancer research, uniting stakeholders in personalized cancer medicine. Researchers, clinicians, advocates, and industry leaders collaborate to advance personalized approaches. By bridging disciplines and sharing knowledge, the program accelerates progress. Emphasizing diversity and inclusivity, it ensures solutions benefit a wide range of patients. PCM is a driving force, revolutionizing cancer care worldwide.
Publications
Position paper by PCM Program steering group members Eskil Degsell and Mats Brommels on the need for a change in perspective in the collaboration between patient, relatives and Health care providers.
Calendar
Datum: February 5, 2024
Plats: IRCCS – Istituto Nazionale dei Tumori, Milano
Information: Cancer Core Europe’s Annual Meeting 2024
Datum: January 31, 2024
Plats: Life City, Solnavägen 3H, Solna
Information: Panel: The future of health: How can patient reported data lead to improved treatments?
